Platinum Equity lines up US$1.9 billion of debt for J&J diabetes care unit bid: Reuters

Private equity firm Platinum Equity’s US$2.1bn offer to acquire blood glucose monitoring systems maker LifeScan, Inc from US health care products company Johnson & Johnson is backed by US$1.875bn of loans, sources told Reuters.